Finepoint Capital LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Finepoint Capital LP disclosed 7 US equity positions worth $543.0m in its Q3 2025 13F filing. The largest position was QXO at 78.3% of the reported book, followed by RXO and SLDB. Against the Q2 2025 filing, it opened 2 new positions, added to 1 and reduced 0 among the top 7 holdings.
What did Finepoint Capital LP own in Q3 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | QXO QXO INC | Industrials | 78.3% | $425.0m | 22,295,615 | 5% | added |
| 2 | RXO RXO INC | Industrials | 20.6% | $111.8m | 7,266,839 | – | new |
| 3 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.1% | $5.9m | 961,251 | 0% | held |
| 4 | ALEANNA INC | 0.0% | $115.9k | 27,717 | 0% | held | |
| 5 | ALEANNA INC | 0.0% | $111.7k | 490,000 | 0% | held | |
| 6 | MoneyHero Ltd | 0.0% | $100.0k | 895,000 | 0% | held | |
| 7 | CALIDI BIOTHERAPEUTICS INC | 0.0% | $1.6k | 1,042 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.